MDS - 824
Elritercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naοve adults with lower-risk myelodysplastic syndromes (MDS) and transfusion-dependent anemia: The ELRiSE MDS phase 3 study
Valeria Santini
Poster Presenter: Valeria Santini
